# Odysight.ai Inc.: overview ODYS · Nasdaq · CIK 1577445 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/odys.md) · [Financials](/companies/odys/financials.md) · [Filings](/companies/odys/filings.md) · [Insiders](/companies/odys/insiders.md) Latest reported revenue: [$420.0k](/filings/0001493152-26-037618.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-037618). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [1,292](/filings/0001493152-25-022127.md) | [1,304 d](/filings/0001493152-26-011691.md) | [2,065](/filings/0001493152-26-023100.md) | [362](/filings/0001493152-26-037618.md) | [149](/filings/0001493152-25-022127.md) | [439 d](/filings/0001493152-26-011691.md) | [82.0](/filings/0001493152-26-023100.md) | [420](/filings/0001493152-26-037618.md) | | Gross margin | % | [31.3%](/filings/0001493152-25-022127.md) | [35.4% d](/filings/0001493152-26-011691.md) | [26.1%](/filings/0001493152-26-023100.md) | [36.7%](/filings/0001493152-26-037618.md) | [15.4%](/filings/0001493152-25-022127.md) | [40.3% d](/filings/0001493152-26-011691.md) | [25.6%](/filings/0001493152-26-023100.md) | [37.9%](/filings/0001493152-26-037618.md) | | Operating margin | % | [(233.4%)](/filings/0001493152-25-022127.md) | [(288.6%) d](/filings/0001493152-26-011691.md) | [(220.8%)](/filings/0001493152-26-023100.md) | [(1226.0%)](/filings/0001493152-26-037618.md) | [(3159.1%)](/filings/0001493152-25-022127.md) | [(1009.1%) d](/filings/0001493152-26-011691.md) | [(6509.8%)](/filings/0001493152-26-023100.md) | [(1078.8%)](/filings/0001493152-26-037618.md) | | Net margin | % | [(221.9%)](/filings/0001493152-25-022127.md) | [(272.7%) d](/filings/0001493152-26-011691.md) | [(206.5%)](/filings/0001493152-26-023100.md) | [(1125.7%)](/filings/0001493152-26-037618.md) | [(2963.8%)](/filings/0001493152-25-022127.md) | [(974.7%) d](/filings/0001493152-26-011691.md) | [(6318.3%)](/filings/0001493152-26-023100.md) | [(1029.5%)](/filings/0001493152-26-037618.md) | | Diluted EPS | $ per share | [(0.23)](/filings/0001493152-25-022127.md) | not reported | [(0.29)](/filings/0001493152-26-023100.md) | [(0.25)](/filings/0001493152-26-037618.md) | [(0.27)](/filings/0001493152-25-022127.md) | not reported | [(0.32)](/filings/0001493152-26-023100.md) | [(0.26)](/filings/0001493152-26-037618.md) | | Free cash flow | $k | [(2,207)](/filings/0001493152-25-022127.md) | [(2,710) d](/filings/0001493152-26-011691.md) | [(2,260)](/filings/0001493152-26-023100.md) | [(4,173)](/filings/0001493152-26-037618.md) | [(3,429)](/filings/0001493152-25-022127.md) | [(3,897) d](/filings/0001493152-26-011691.md) | [(4,260)](/filings/0001493152-26-023100.md) | [(4,487)](/filings/0001493152-26-037618.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.4](/filings/0001493152-23-009276.md) | [0.7](/filings/0001493152-24-011341.md) | [3.0](/filings/0001641172-25-000677.md) | [4.0](/filings/0001493152-26-011691.md) | [3.0](/filings/0001493152-26-011691.md) | | Gross margin | % | [(186.3%)](/filings/0001493152-23-009276.md) | [(145.3%)](/filings/0001493152-24-011341.md) | [16.8%](/filings/0001641172-25-000677.md) | [29.2%](/filings/0001493152-26-011691.md) | [28.9%](/filings/0001493152-26-011691.md) | | Operating margin | % | [(2354.5%)](/filings/0001493152-23-009276.md) | [(1419.4%)](/filings/0001493152-24-011341.md) | [(350.6%)](/filings/0001641172-25-000677.md) | [(315.5%)](/filings/0001493152-26-011691.md) | [(601.5%)](/filings/0001493152-26-011691.md) | | Net margin | % | [(2322.2%)](/filings/0001493152-23-009276.md) | [(1423.8%)](/filings/0001493152-24-011341.md) | [(311.4%)](/filings/0001641172-25-000677.md) | [(296.8%)](/filings/0001493152-26-011691.md) | [(565.0%)](/filings/0001493152-26-011691.md) | | Diluted EPS | $ per share | [(1.44)](/filings/0001493152-22-008167.md) | [(1.33)](/filings/0001493152-24-011341.md) | [(0.98)](/filings/0001641172-25-000677.md) | [(1.03)](/filings/0001493152-26-011691.md) | [(1.07)](/filings/0001493152-26-011691.md) | | Free cash flow | $m | [(6.5)](/filings/0001493152-23-009276.md) | [(6.2)](/filings/0001493152-24-011341.md) | [(10.1)](/filings/0001641172-25-000677.md) | [(8.3)](/filings/0001493152-26-011691.md) | [(13.8)](/filings/0001493152-26-011691.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/odys/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Phoenix Financial Ltd.](/funds/1679543.md) | 2026-06-30 | $7.7m | 1,854,678 | | Reduced −198,844 | | [Y.D. More Investments Ltd](/funds/1870364.md) | 2026-06-30 | $2.7m | 648,776 | | Reduced −324,767 | | [Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD](/funds/1639753.md) | 2026-06-30 | $2.6m | 624,737 | | Unchanged | | [Yelin Lapidot Holdings Management Ltd.](/funds/1590495.md) | 2026-06-30 | $855.4k | 205,629 | | Reduced −4,482 | | [Noked Israel Ltd](/funds/1767750.md) | 2026-06-30 | $836.0k | 200,972 | | Unchanged | | [Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD](/funds/1639754.md) | 2026-06-30 | $821.2k | 196,000 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $153.8k | 36,966 | | Added +9,714 | | [MEITAV INVESTMENT HOUSE LTD](/funds/1398346.md) | 2026-06-30 | $130.5k | 31,296 | | Unchanged | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $123.7k | 29,738 | | Added +18,214 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $86.2k | 20,546 | | New +20,546 | ## Recent filings [All 319 filings](/companies/odys/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-09 | 15:19 ET | [SCHEDULE 13D](/filings/0001178913-26-004462.md) | Ownership report, active investor | 0001178913-26-004462 | | 2026-08-21 | 08:50 ET | [8-K](/filings/0001493152-26-039574.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-039574 | | 2026-08-20 | 06:05 ET | [8-K](/filings/0001493152-26-039335.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-039335 | | 2026-08-13 | 09:27 ET | [8-K](/filings/0001493152-26-037619.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037619 | | 2026-08-13 | 09:24 ET | [10-Q](/filings/0001493152-26-037618.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037618 | | 2026-06-05 | 16:57 ET | [8-K](/filings/0001493152-26-027515.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-027515 | | 2026-05-21 | 16:07 ET | [8-K](/filings/0001493152-26-024819.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-024819 | | 2026-05-14 | 16:25 ET | [8-K](/filings/0001493152-26-023116.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023116 | | 2026-05-14 | 16:16 ET | [10-Q](/filings/0001493152-26-023100.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023100 | | 2026-04-10 | 09:15 ET | [8-K](/filings/0001493152-26-016059.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016059 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-011691.md), filed Mar 19, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f3deeaf5-3beb-4dd7-b87b-4e6bc0b5ca88) ## About the filer - CIK: 1577445 - Tickers: ODYS - Exchange: Nasdaq - SIC code: 7373 Services-Computer Integrated Systems Design - State of incorporation: not reported - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.